New Drug for Recurring Cases of Breast Cancer
498234
(Dec. 8) -- Researchers believe they have a better drug for preventing recurring cases of breast cancer. After breast cancer surgery, women are often given the drug Tamoxifen to keep the cancer from coming back.
197102
Older women suffering from breast cancer should take a newer drug in place of the tried-and-true tamoxifen, researchers from the US and Britain have announced.
393648
GlaxoSmithKline's new breast cancer pill Tykerb might help prevent the growth of tumors in some people with a hard-to-treat form of the disease, U.S. researchers reported on Sunday.
98244
Most women who have breast cancer and are past menopause should take a type of hormone-blocking drug known as an aromatase inhibitor to prevent cancer recurrence, experts said Monday.
618283
WEDNESDAY, Oct. 17 (HealthDay News) -- A new chemotherapy drug called Ixempra has received U.S. Food and Drug Administration approval to treat women with advanced breast cancer who haven't responded to three other types of chemotherapy.
446242
Raloxifene (Evista) continues to be associated with more than a 50% reduction in breast cancer incidence beyond the first 4 years of treatment, according to a new study in the December 1 issue of the Journal of the National Cancer Institute.
423651
FRIDAY, Nov. 17 (HealthDay News) -- Certain breast cancer patients who switch to the aromatase inhibitor drug anastrozole (Arimidex) after two to three years of treatment with tamoxifen live longer and are more likely to remain cancer-free, German researchers report.
542831
British women who have had breast cancer can now have a new treatment which has been found to prevent the disease returning and to prolong survival.
248078
A drug can treat  menopausal symptoms among women on tamoxifen therapy for breast cancer, say scientists.
250736
WEDNESDAY, Dec. 26 (HealthDay News)-- Chemotherapy drugs known as anthracyclines help boost survival for women with HER2-positive breast cancer who have undergone surgery, but they may not offer any survival benefit for those with HER2-negative tumors.
53226
THE REPORT: Doctors are reporting that a new breast cancer drug, Arimidex, and others in its class outperform the tried-and-true tamoxifen at preventing recurrence in older women.
232184
Women diagnosed with breast cancer should be given a new drug instead of the standard treatment because it is safer, more effective and may increase overall survival rates, doctors have suggested.
530863
The US Food and Drug Administration (FDA) approved a new genetic test of the likelihood of recurring breast cancer, five to ten years after its onset.
638713
A new type of cancer drug being  developed by Bristol-Myers Squibb Co., when combined with a  standard chemotherapy, was significantly better than  chemotherapy alone in delaying progression of advanced breast  cancer, a researcher said on Sunday.
754325
NEW YORK  - After approximately 8 years, postmenopausal women with hormone-sensitive breast cancer who received (Arimidex), generically known as anastrazole, had a lower risk of recurrence than women taking tamoxifen, investigators reported at the annual meeting of the San Antonio Breast Cancer Symposium.
643980
NEW YORK  - The American Society of Clinical Oncology (ASCO) now recommends that a third-generation aromatase inhibitor be included as adjuvant hormonal therapy for postmenopausal women with receptor-positive breast cancer.
320147
Cancer drug shows exceptional promise as it moves toward FDA review.